肿瘤活性-话题@MedSci

#肿瘤活性#

40篇内容 | 1707人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2034536, encodeId=37732034536bb, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=CLIN CANCER RES：靶向PCNA小分子的抗肿瘤活性, objectType=article, longId=156171, objectId=178b1561e1c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=178b1561e1c2, replyNumber=0, likeNumber=77, createdTime=2019-04-12, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=178b1561e1c2, moduleTitle=CLIN CANCER RES：靶向PCNA小分子的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=178b1561e1c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034535, encodeId=88b02034535a3, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet oncol：瑞戈非尼用于晚期骨肉瘤成人患者，具有明显的抗肿瘤活性，可延缓病程进展, objectType=article, longId=154390, objectId=6b3115439045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b3115439045, replyNumber=0, likeNumber=92, createdTime=2019-01-27, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b3115439045, moduleTitle=Lancet oncol：瑞戈非尼用于晚期骨肉瘤成人患者，具有明显的抗肿瘤活性，可延缓病程进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b3115439045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034528, encodeId=6c56203452881, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性, objectType=article, longId=133918, objectId=05b213391822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05b213391822, replyNumber=0, likeNumber=65, createdTime=2018-11-10, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05b213391822, moduleTitle=J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05b213391822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034530, encodeId=6d642034530b5, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性, objectType=article, longId=140166, objectId=017e140166f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=017e140166f6, replyNumber=0, likeNumber=80, createdTime=2018-08-30, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=017e140166f6, moduleTitle=CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=017e140166f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034529, encodeId=aa39203452950, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Cell Death Dis：研究首次发现Corylin具有抗肿瘤活性, objectType=article, longId=138264, objectId=9a871382647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a871382647f, replyNumber=0, likeNumber=74, createdTime=2019-04-13, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a871382647f, moduleTitle=Cell Death Dis：研究首次发现Corylin具有抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a871382647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034532, encodeId=1f6320345329d, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, objectType=article, longId=148662, objectId=655114866244, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=655114866244, replyNumber=0, likeNumber=106, createdTime=2019-01-10, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=655114866244, moduleTitle=Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=655114866244)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034526, encodeId=5b6d20345262f, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Lancet Onco：希望！新药治疗复发性BRCA卵巢癌可产显著持久抗肿瘤活性！, objectType=article, longId=127553, objectId=9fd512e553f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fd512e553f9, replyNumber=0, likeNumber=61, createdTime=2018-06-16, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fd512e553f9, moduleTitle=Lancet Onco：希望！新药治疗复发性BRCA卵巢癌可产显著持久抗肿瘤活性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fd512e553f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034524, encodeId=705a20345248f, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性, objectType=article, longId=119453, objectId=969e1194535f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=969e1194535f, replyNumber=0, likeNumber=75, createdTime=2018-09-29, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=969e1194535f, moduleTitle=JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=969e1194535f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034531, encodeId=e82120345317c, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=CLIN CANCER RES：阻断化疗诱导的TGFβ1信号可以增强抗肿瘤活性, objectType=article, longId=141983, objectId=54b31419833c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54b31419833c, replyNumber=0, likeNumber=48, createdTime=2018-07-27, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54b31419833c, moduleTitle=CLIN CANCER RES：阻断化疗诱导的TGFβ1信号可以增强抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54b31419833c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034521, encodeId=819d20345214c, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Oncotarget：miR-33a抑制前列腺癌肿瘤活性, objectType=article, longId=107646, objectId=172c10e646f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172c10e646f2, replyNumber=0, likeNumber=62, createdTime=2018-04-30, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172c10e646f2, moduleTitle=Oncotarget：miR-33a抑制前列腺癌肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172c10e646f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034527, encodeId=204b203452eb9, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Chem Sci：抗肿瘤活性分子生物合成研究进展, objectType=article, longId=129356, objectId=c556129356af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c556129356af, replyNumber=0, likeNumber=64, createdTime=2018-12-25, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c556129356af, moduleTitle=Chem Sci：抗肿瘤活性分子生物合成研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c556129356af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034522, encodeId=5f4d203452205, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究, objectType=article, longId=111067, objectId=776311106e61, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=776311106e61, replyNumber=0, likeNumber=72, createdTime=2018-07-01, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=776311106e61, moduleTitle=JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=776311106e61)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034523, encodeId=04f02034523e5, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, objectType=article, longId=116540, objectId=d02a116540e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d02a116540e5, replyNumber=0, likeNumber=64, createdTime=2018-06-29, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d02a116540e5, moduleTitle=J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d02a116540e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034525, encodeId=a583203452574, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Sci Rep：下一代抗疟疾药物-二茂铁氯喹具有抗肿瘤活性, objectType=article, longId=121430, objectId=eaa41214309c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaa41214309c, replyNumber=0, likeNumber=67, createdTime=2018-11-06, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaa41214309c, moduleTitle=Sci Rep：下一代抗疟疾药物-二茂铁氯喹具有抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaa41214309c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034520, encodeId=e9d4203452020, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）, objectType=article, longId=102865, objectId=a98d102865b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a98d102865b0, replyNumber=0, likeNumber=91, createdTime=2017-07-20, rootId=0, userName=mhm289, userId=af60254, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a98d102865b0, moduleTitle=J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a98d102865b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034519, encodeId=08c1203451923, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性, objectType=article, longId=100552, objectId=168c1005523e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=168c1005523e, replyNumber=0, likeNumber=75, createdTime=2017-12-05, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=168c1005523e, moduleTitle=Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=168c1005523e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034518, encodeId=5d2c203451841, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性, objectType=article, longId=95153, objectId=4bce95153da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bce95153da, replyNumber=0, likeNumber=88, createdTime=2018-03-22, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bce95153da, moduleTitle=Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bce95153da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034517, encodeId=4b7b203451e3a, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Sci Rep：尿酸能增强树突状细胞瘤苗的抗肿瘤活性, objectType=article, longId=59520, objectId=402659520c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=402659520c9, replyNumber=0, likeNumber=64, createdTime=2016-10-20, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402659520c9, moduleTitle=Sci Rep：尿酸能增强树突状细胞瘤苗的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=402659520c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034515, encodeId=b6052034515dc, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=Clin Cancer Res：色瑞替尼对ALK阳性的非小细胞肺癌有显著的抗肿瘤活性, objectType=article, longId=47739, objectId=6fb64e739f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb64e739f8, replyNumber=0, likeNumber=73, createdTime=2015-06-09, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb64e739f8, moduleTitle=Clin Cancer Res：色瑞替尼对ALK阳性的非小细胞肺癌有显著的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fb64e739f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2034516, encodeId=33512034516e3, content=<a href='/topic/show?id=3a9382989a2' target=_blank style='color:#2F92EE;'>#肿瘤活性#</a>, objectTitle=NEJM：Pembrolizumab用于晚期NSCLC展现出良好抗肿瘤活性（KEYNOTE-001研究）, objectType=article, longId=49813, objectId=9a844981343, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a844981343, replyNumber=0, likeNumber=73, createdTime=2016-01-15, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a844981343, moduleTitle=NEJM：Pembrolizumab用于晚期NSCLC展现出良好抗肿瘤活性（KEYNOTE-001研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a844981343)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤活性

2020-05-29

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

CLIN CANCER RES：靶向PCNA小分子的抗肿瘤活性

2019-04-12

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet oncol：瑞戈非尼用于晚期骨肉瘤成人患者，具有明显的抗肿瘤活性，可延缓病程进展

2019-01-27

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

J Clin Oncol：II期临床显示Crizotinib在东亚患者中具有抗肿瘤活性

2018-11-10

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

CLIN CANCER RES：PD-1阻断和CD27活化可以协同增强CD8+T细胞抗肿瘤活性

2018-08-30

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Cell Death Dis：研究首次发现Corylin具有抗肿瘤活性

2019-04-13

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Brit J Cancer：派姆单抗对晚期粘膜黑色素瘤患者的抗肿瘤活性

2019-01-10

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Lancet Onco：希望！新药治疗复发性BRCA卵巢癌可产显著持久抗肿瘤活性！

2018-06-16

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

JCO：Pembrolizumab治疗晚期食管癌的安全性和抗肿瘤活性

2018-09-29

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

CLIN CANCER RES：阻断化疗诱导的TGFβ1信号可以增强抗肿瘤活性

2018-07-27

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Oncotarget：miR-33a抑制前列腺癌肿瘤活性

2018-04-30

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Chem Sci：抗肿瘤活性分子生物合成研究进展

2018-12-25

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

JCO：派姆单抗治疗PD-L1阳性鼻咽癌患者的安全性及抗肿瘤活性研究

2018-07-01

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

J Clin Oncol：BTK抑制剂伊布替尼在复发难治B细胞恶性肿瘤患者中具有显著的抗肿瘤活性

2018-06-29

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

Sci Rep：下一代抗疟疾药物-二茂铁氯喹具有抗肿瘤活性

2018-11-06

mhm289 (审核中...)

前往app查看评论内容

#肿瘤活性#

J CLIN ONCOL: Pembrolizumab治疗晚期程序性死亡因子配体 1-阳性的子宫内膜癌的安全及抗肿瘤活性（KEYNOTE-028）

2017-07-20

医者仁心 (审核中...)

前往app查看评论内容

#肿瘤活性#

Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性

2017-12-05

医者仁心 (审核中...)

前往app查看评论内容

#肿瘤活性#

Brit J Cancer：低密度脂蛋白胆固醇能够抵消酪氨酸激酶抑制剂对肾细胞上皮癌的抗肿瘤活性

2018-03-22

医者仁心 (审核中...)

前往app查看评论内容

#肿瘤活性#

Sci Rep：尿酸能增强树突状细胞瘤苗的抗肿瘤活性

2016-10-20

医者仁心 (审核中...)

前往app查看评论内容

#肿瘤活性#

Clin Cancer Res：色瑞替尼对ALK阳性的非小细胞肺癌有显著的抗肿瘤活性

2015-06-09

医者仁心 (审核中...)

前往app查看评论内容

#肿瘤活性#

NEJM：Pembrolizumab用于晚期NSCLC展现出良好抗肿瘤活性（KEYNOTE-001研究）

2016-01-15

科室
- - 订阅+
  - 更多科室
工具
服务